UnitedHealth Group Inc. (UNH) Upgraded to “Buy” at Vetr Inc.
UnitedHealth Group Inc. (NYSE:UNH) was upgraded by equities researchers at Vetr to a “buy” rating in a research note issued on Friday.
Several other equities research analysts also recently weighed in on UNH. Wedbush reissued an “outperform” rating and issued a $165.00 price objective on shares of UnitedHealth Group in a report on Tuesday, July 19th. Argus raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 price objective for the company in a report on Friday, July 22nd. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, June 21st. Citigroup Inc. increased their price objective on UnitedHealth Group from $148.00 to $164.00 and gave the company a “buy” rating in a report on Wednesday, July 20th. Finally, Credit Suisse Group AG reissued a “buy” rating and issued a $148.00 price objective on shares of UnitedHealth Group in a report on Wednesday, June 29th. One analyst has rated the stock with a hold rating, twenty-five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $155.35.
UnitedHealth Group (NYSE:UNH) traded up 0.14% during trading on Friday, hitting $136.66. 2,568,703 shares of the stock traded hands. The firm’s 50-day moving average is $137.80 and its 200-day moving average is $136.35. UnitedHealth Group has a 12 month low of $107.51 and a 12 month high of $144.48. The stock has a market cap of $130.15 billion, a P/E ratio of 21.39 and a beta of 0.57.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/07/unitedhealth-group-inc-unh-upgraded-to-buy-at-vetr-inc.html
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.89 by $0.07. The firm earned $46.50 billion during the quarter, compared to the consensus estimate of $45.05 billion. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. On average, analysts forecast that UnitedHealth Group will post $7.90 EPS for the current year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Friday, September 9th were paid a $0.625 dividend. This represents a $2.50 dividend on an annualized basis and a yield of 1.83%. The ex-dividend date was Tuesday, September 6th. UnitedHealth Group’s payout ratio is 39.12%.
In other UnitedHealth Group news, Director Richard T. Burke sold 40,000 shares of the firm’s stock in a transaction dated Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total value of $5,412,400.00. Following the sale, the director now directly owns 2,003,550 shares of the company’s stock, valued at approximately $271,100,350.50. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 1.65% of the stock is owned by company insiders.
A number of hedge funds have recently modified their holdings of the company. Van Hulzen Asset Management LLC purchased a new position in UnitedHealth Group during the second quarter valued at $104,000. Archford Capital Strategies LLC raised its position in UnitedHealth Group by 669.2% in the second quarter. Archford Capital Strategies LLC now owns 800 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 696 shares in the last quarter. MCF Advisors LLC raised its position in UnitedHealth Group by 312.9% in the first quarter. MCF Advisors LLC now owns 958 shares of the healthcare conglomerate’s stock valued at $123,000 after buying an additional 726 shares in the last quarter. Hanson McClain Inc. raised its position in UnitedHealth Group by 0.4% in the second quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock valued at $126,000 after buying an additional 4 shares in the last quarter. Finally, Howe & Rusling Inc. raised its position in UnitedHealth Group by 4.5% in the second quarter. Howe & Rusling Inc. now owns 920 shares of the healthcare conglomerate’s stock valued at $130,000 after buying an additional 40 shares in the last quarter. 85.78% of the stock is currently owned by hedge funds and other institutional investors.
About UnitedHealth Group
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
To view Vetr’s full report, visit Vetr’s official website.
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.